These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3382232)

  • 1. [Evaluation of BRM in skin cancer].
    Ishihara K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1603-8. PubMed ID: 3382232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of intratumoral administration of BRM in advanced cancer and their mechanism of actions].
    Kuninobu H; Toge T; Takayama T; Baba N; Kegoya Y; Yanagawa E
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2769-73. PubMed ID: 2782888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the behalf of the Japanese Society of Biological Response Modifiers].
    Ishihara K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):906-11. PubMed ID: 2730029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein deficiency, host defense and natural anti-tumor immunity].
    Ruffmann R; Schlick E; Tartaris T; Chirigos MA
    Infusionsther Klin Ernahr; 1986 Apr; 13(2):106-12. PubMed ID: 3519454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of BRMs in gastric cancer patients].
    Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1609-14. PubMed ID: 2968070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant and premalignant skin conditions.
    Mehta R
    Practitioner; 2003 Feb; 247(1643):104-7, 109, 112-4 passim. PubMed ID: 12621803
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological response modifiers in regional cancer therapy.
    Bergh JC
    Eur J Surg Suppl; 1991 May; (561):87-90. PubMed ID: 1720055
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response modifiers and cutaneous neoplasia.
    Spencer JM
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):17-21. PubMed ID: 19667609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI preclinical screen of biological response modifiers.
    Talmadge JE; Fidler IJ; Oldham RK
    Behring Inst Mitt; 1984 May; (74):189-94. PubMed ID: 6206841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant application of interferons.
    el Kassas H; Kirkwood JM
    Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of cutaneous T-cell lymphoma.
    Vonderheid EC; Micaily B
    Dermatol Clin; 1985 Oct; 3(4):673-87. PubMed ID: 3916174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological response modifiers.
    Oldham RK
    J Natl Cancer Inst; 1983 May; 70(5):789-96. PubMed ID: 6188871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Response Modifiers Programme and cancer chemotherapy.
    Oldham RK
    Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts.
    Feng N; Jin H; Wang M; Du C; Wright JA; Young AH
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):247-55. PubMed ID: 12655444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
    Silver DF; Hempling RE; Piver MS; Repasky EA
    Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local administration of immunomodulators.
    Pinsky CM
    Semin Oncol; 1986 Jun; 13(2):141-3. PubMed ID: 3520824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC; Burgdorf WH; Wollenberg A
    Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional treatment of malignant hepatic tumors with biologic response modifiers.
    Yamamoto A; Sato T
    Surg Oncol Clin N Am; 2008 Oct; 17(4):935-55, xii. PubMed ID: 18722927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of biological responses: what to measure and when.
    Maluish AE; Herberman RB
    Cancer Treat Rep; 1985 Oct; 69(10):1165-9. PubMed ID: 3899356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.